Brickell Biotech Depreciation & Amortization 2011-2026 | BBI

Annual Depreciation & Amortization Brickell Biotech

2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
41 K	30 K	22 K	10 K	28 K	151 K	793 K	1.12 M	1.16 M	1.66 M	2.21 M	1.98 M	2.3 M

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
2.3 M	10 K	885 K

Quarterly Depreciation & Amortization Brickell Biotech

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	10 K	-	-	13 K	7 K	-	-	8 K	1 K	-	9 K	6 K	3 K	-	25 K	21 K	13 K	-	37 K	119 K	64 K	-	722 K	526 K	267 K	-	836 K	556 K	277 K	-	884 K	595 K	301 K	-	1.33 M	940 K	467 K	-	1.73 M	1.2 M	620 K	-	1.69 M	981 K	493 K	-	1.75 M	1.16 M	579 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.75 M	1 K	521 K

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
Acer Therapeutics ACER	66 K	-	2.71 %	$ 14 M	USA
Amarin Corporation plc AMRN	200 K	$ 14.58	-2.93 %	$ 5.94 B	Irlanda
Aptorum Group Limited APM	1.13 M	$ 0.82	-2.71 %	$ 4.47 M	China
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Acasti Pharma ACST	7 K	-	4.01 %	$ 150 M	Canada
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
Adagene ADAG	723 K	$ 2.99	0.17 %	$ 168 M	China
AlloVir ALVR	398 K	-	4.14 %	$ 49.1 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
ARCA biopharma ABIO	27 K	-	1052.0 %	$ 415 M	USA
Aptose Biosciences APTO	32 K	-	-45.71 %	$ 1.2 M	Canada
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Athira Pharma ATHA	970 K	-	-	$ 269 M	USA
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Albireo Pharma ALBO	274 K	-	-0.23 %	$ 916 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
Codexis CDXS	4.95 M	$ 1.2	-4.4 %	$ 88.1 M	USA
Arena Pharmaceuticals ARNA	3.87 M	-	-6.81 %	$ 3.04 B	USA
BeiGene, Ltd. BGNE	172 M	-	0.49 %	$ 251 B	Cayman-islands
Aridis Pharmaceuticals ARDS	487 K	-	17.91 %	$ 11.1 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	131 K	-	-10.17 %	$ 12.2 K	USA
Athersys ATHX	1.43 M	-	3.77 %	$ 22.4 M	USA
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Baudax Bio BXRX	165 K	-	0.59 %	$ 63 K	USA
Cabaletta Bio CABA	1.43 M	$ 2.54	-2.38 %	$ 2.97 M	USA
Calithera Biosciences CALA	300 K	-	-10.95 %	$ 876 K	USA
Autolus Therapeutics plc AUTL	7.55 M	$ 1.4	-2.45 %	$ 357 M	Britain
Amneal Pharmaceuticals AMRX	62.6 M	$ 14.71	-0.34 %	$ 4.55 B	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
AVROBIO AVRO	617 K	-	1083.1 %	$ 745 M	USA
Can-Fite BioPharma Ltd. CANF	14 K	$ 4.28	-1.34 %	$ 9.31 B	Israel